Last reviewed · How we verify
SHR2554 and Itraconazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
SHR2554 and Itraconazole (SHR2554 and Itraconazole) — Jiangsu HengRui Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SHR2554 and Itraconazole TARGET | SHR2554 and Itraconazole | Jiangsu HengRui Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SHR2554 and Itraconazole CI watch — RSS
- SHR2554 and Itraconazole CI watch — Atom
- SHR2554 and Itraconazole CI watch — JSON
- SHR2554 and Itraconazole alone — RSS
Cite this brief
Drug Landscape (2026). SHR2554 and Itraconazole — Competitive Intelligence Brief. https://druglandscape.com/ci/shr2554-and-itraconazole. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab